Whaley Glenn bought IMUX
July 16, 2025 · Form 4 insider transaction
Whaley Glenn bought 280,000 shares of Immunic, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
280,000
Price
$0.00
Total value
N/A
InsiderWhaley Glenn
Role—
CompanyImmunic, Inc. (IMUX)
SecurityStock Appreciation Right
Transaction codeA: Grant or award
Transaction dateJuly 16, 2025
Filing dateJuly 18, 2025
Shares owned after280,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Stock Appreciation Rights ("SARs") could be settled for cash, but it is the intention of the Issuer that these SARs will be settled for shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") provided the Issuer obtains stockholder approval to amend the Issuer's 2019 Omnibus Equity Incentive Plan, as amended, to provide for a sufficient number of shares of Common Stock to support the settlement of the SARs in shares of Common Stock.